Previous studies have suggested that the drugs known as GLP-1s, or glucagon-like peptide-1 receptor agonists, could reduce addictions by targeting the brain’s reward pathways. But those studies have been small and often limited to one substance.
Based on the new Canadian Antibiotic Treatment Guidance resource, which statement about recommended empiric treatments for mild to moderate community-acquired pneumonia in adults is FALSE?
New Canadian resource is designed to help prescribers make evidence-based decisions for treating infections in primary care and to promote better antibiotic stewardship.
A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.
